Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity
about
Loss of Rho GDIα and resistance to tamoxifen via effects on estrogen receptor αESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signalingLeptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cellsEstrogen receptor (ER) α mutations in breast cancer: hidden in plain sightEstrogen receptor mutations and changes in downstream gene expression and signalingPost-translational modifications of nuclear receptors and human diseaseThe role of S6K1 in ER-positive breast cancer.The pioneer factor PBX1 is a novel driver of metastatic progression in ERα-positive breast cancerEstrogen receptors and human disease: an update.G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.ESR1 mutations—a mechanism for acquired endocrine resistance in breast cancer.Phosphorylation: a fundamental regulator of steroid receptor action.Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancer.Detection of ESR1 mutations in plasma and tumors from metastatic breast cancer patients using next-generation sequencing.Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth.Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells.Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cellsThe estrogen receptor alpha-derived peptide ERα17p (P(295)-T(311)) exerts pro-apoptotic actions in breast cancer cells in vitro and in vivo, independently from their ERα status.
P2860
Q28308069-DA19DF23-D42D-4431-A0A3-316AB4CC12F3Q33903949-51ED5E34-0F68-4315-B1B8-219F39A6B2E4Q34010406-1D9B628E-90C1-4244-80FF-F0E2DEEC37E9Q34010413-506243C7-00A4-4219-82A0-EC978B7A11DDQ34112728-E5AD63AB-C493-4EBE-ADEB-2169F7BC8AA7Q35842790-1E981B9C-E88A-40C6-A195-B3705DCE0ACBQ36304094-E2B49172-7941-4CB7-B86A-D4EB2D37776EQ36355823-499F156F-91FC-4090-B4CD-8EA3E768461EQ36661810-AFDD13EA-51B9-46A5-8B48-E1A78B5C035CQ36690093-7340B1BB-316C-4A2D-BDFB-6312231D7611Q37013898-57C1C0E7-6BBE-4092-A0F8-F946A2F66833Q37198642-26025A03-AC8E-4E99-A021-C952C27A0149Q37671724-57132BF1-1B89-4D9A-B960-F0A92D0B33A9Q38913843-AD1F43B2-C2A8-4CE3-B780-0875879D034EQ38984903-62F3286E-52FC-4642-B0C8-12AF2F1A1244Q39183133-FB84D817-7360-4823-BCD3-C81C3C66FE49Q39228672-3ACC42F6-E2C1-413E-B5CB-3DF62B64C216Q39619285-EE24F21F-93B2-4F5D-A847-9718FE5FD761
P2860
Phosphorylation of the mutant K303R estrogen receptor alpha at serine 305 affects aromatase inhibitor sensitivity
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@ast
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@en
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@nl
type
label
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@ast
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@en
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@nl
prefLabel
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@ast
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@en
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@nl
P2093
P2860
P356
P1433
P1476
Phosphorylation of the mutant ...... romatase inhibitor sensitivity
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2009.520
P407
P577
2010-01-25T00:00:00Z
P5875
P6179
1032250545